Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
Nizar El-KhaliliAlpine Clinic, Lafayette, IN, USAAbstract: The atypical antipsychotic quetiapine fumarate is available both as an immediate release (IR) and as an extended release (XR) formulation allowing flexibility of dosing for individual patients. Approved uses of quetiapine XR include the trea...
Guardado en:
Autor principal: | El-Khalili N |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1db1c6c01955411cad9df411929cecd3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The management of schizophrenia: focus on extended-release quetiapine fumarate
por: Peuskens J
Publicado: (2011) -
Role of extended release quetiapine in the management of bipolar disorders
por: Rayan K Al Jurdi, et al.
Publicado: (2010) -
Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder
por: Endicott J, et al.
Publicado: (2012) -
Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
por: Prashant Gajwani, et al.
Publicado: (2007) -
Quetiapine monotherapy for bipolar depression
por: Michael E Thase
Publicado: (2008)